SCHEMBL6556065

SCHEMBL6556065

O=C(Nc1ccc(-c2ccccc2)[nH]c1=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
MGLL Q99685 2/20 0.51
PTPN1 P18031 2/20 0.50
CASP3 P42574 1/20 0.50
MAOB P27338 1/20 0.48
POLB P06746 1/20 0.47
ENPP2 Q13822 2/20 0.46
ROCK2 O75116 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP12 P39900 1/20 0.44
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7276441 0.90 ALDH1A1 (0.51) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL7276750 0.89 RAB9A (0.48) NPC1RAB9APTPN1CASP3MAOB
SCHEMBL7276640 0.86 MGLL (0.46) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL1330921 0.84 CASP3 (0.51) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL4416727 0.83 NPC1 (0.62) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL948055 0.82 NPC1 (0.53) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL7342183 0.81 NPC1 (0.56) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL7283277 0.81 NPC1 (0.52) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL5113764 0.80 NPC1 (0.54) NPC1RAB9AMGLLPTPN1CASP3
SCHEMBL11261916 0.79 KDM4E (0.57) NPC1RAB9AMGLLPTPN1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0826671-B1 HETEROCYCLIC AMIDE COMPOUNDS AND MEDICINAL USE OF THE SAME MITSUBISHI PHARMA CORP (JP) 2004-12-29 EP disclosed
US-5948785-A USEFUL AS CHYMASE INHIBITORS AND CAN BE EFFECTIVE FOR THE PROPHYLAXIS AND TREATMENT OF VARIOUS DISEASES CAUSED BY CHYMASE, SUCH AS THOSE CAUSED BY ANGIOTENSIN II. THE GREEN CROSS CORPORATION (JP) 1999-09-07 US disclosed
WO-1998045266-A1 3-AMINOPYRIDINE DERIVATIVES FOR TREATMENT OF INFLAMMATORY AND MALIGNANT DISEASES FERRING B.V. (NL) 1998-10-15 WO disclosed
EP-0826671-A1 HETEROCYCLIC AMIDE COMPOUNDS AND MEDICINAL USE OF THE SAME THE GREEN CROSS CORPORATION (JP) 1998-03-04 EP disclosed
EP-0509769-B1 Heterocyclic amides having HLE inhibiting activity ZENECA LTD (GB) 1996-09-11 EP disclosed
US-5521179-A Heterocyclic amides ZENECA LIMITED (GB) 1996-05-28 US disclosed
EP-0509769-A2 Heterocyclic amides having HLE inhibiting activity ZENECA LIMITED (GB) 1992-10-21 EP disclosed